Shahin Merat, a trial investigator and professor at the Tehran University of Medical Sciences, told the Financial Times: “Because of the sanctions, most drugs were not available to us early enough. We had no choice other than to work with what we have . . . This one, it turned out, appears to work.” Dr Merat owns shares in Rojan
US official Anthony Fauci says sofosbuvir and daclatasvir results are ‘provocative and encouraging’
A combination of antiviral drugs used to cure millions of Hepatitis C patients has shown promising results as a Covid-19 treatment in hospital trials in Iran.
In results from three trials, 94 per cent of hospitalised patients taking a combination of sofosbuvir and daclatasvir showed reduced fevers and improved breathing versus 70 per cent in the control arm.
The death rate for those given the drugs was just 5 per cent compared with 20 per cent for those who were not.
US official Anthony Fauci says sofosbuvir and daclatasvir results are ‘provocative and encouraging’
A combination of antiviral drugs used to cure millions of Hepatitis C patients has shown promising results as a Covid-19 treatment in hospital trials in Iran.
In results from three trials, 94 per cent of hospitalised patients taking a combination of sofosbuvir and daclatasvir showed reduced fevers and improved breathing versus 70 per cent in the control arm.
The death rate for those given the drugs was just 5 per cent compared with 20 per cent for those who were not.
Comments
Be the first to add a comment
Log in to comment